Skip to main content

Felicia Ruffin

Research Program Leader, Tier 1
Medicine, Infectious Diseases
Box 102359 DUMC, Durham, NC 27710
0207 F Hosp South, Durham, NC 27710

Selected Grants


Genomic determinants of antibiotic treatment failure in S. aureus bacteremia

ResearchClinical Research Coordinator · Awarded by National Institutes of Health · 2024 - 2029

Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient Mortality

ResearchResearch Program Leader · Awarded by National Institutes of Health · 2022 - 2027

HLA Fine Mapping to Elucidate S. aureus Susceptibility - R01 RPPR

ResearchClinical Research Nurse · Awarded by National Institutes of Health · 2021 - 2026

Proof of Principle Study

ResearchClinical Research Coordinator · Awarded by Research of Technologies and Biophotonics LTD · 2024 - 2025

Identification of novel pathogen-specific drug targets in gram-negative bacteria (JCVI CDC U54 - Medium Collaborative)

ResearchResearch Program Leader · Awarded by J. Craig Venter Institute · 2021 - 2025

Innate immune induction of antibiotic tolerance and resistance in Staphylococcus aureus - R56 Bridge Funding (for R01 submission)

ResearchProject Manager · Awarded by University of North Carolina - Chapel Hill · 2022 - 2024

Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria

ResearchClinical Research Coordinator II · Awarded by National Institutes of Health · 2011 - 2022

Systems Immunobiology of Antibiotic-Persistent MRSA Infections

ResearchClinical Research Coordinator II · Awarded by The Lundquist Institute · 2016 - 2021

Forces at the heart of Staphylococcus biofilms on cardiac implants

ResearchResearch Coordinator · Awarded by Ohio State University · 2014 - 2020

Host Susceptibility to S. aureus

ResearchResearch Associate · Awarded by National Institutes of Health · 2012 - 2020